Cagrilintide is a long-acting analog of amylin, a peptide hormone co-secreted with insulin by pancreatic β-cells. It is a calcitonin receptor agonist and has been studied for its effects on appetite regulation, gastric emptying, and energy balance. Research shows that Cagrilintide can reduce food intake and promote weight loss by enhancing satiety signals in the central nervous system.

In experimental models, it is often combined with GLP-1 receptor agonists like Tirzepatide or Semaglutide to study synergistic effects on metabolic health, body composition, and glucose control.

For research use only. Not for human or veterinary use.

Products are provided in lyophilized powder form and require reconstitution prior to use in research or laboratory testing.